AeHuIFN a A( 30-43)-( 123-137)-NH2, Ac-Leu-Lys-Asp-Arg-His-Asp-Phe-Gly-PhePro-Gln-Glu-Glu-Phe-Phe-Gln-Arg-Ile-Thr-Leu-Tyr-Leu-Lys-Glu-Lys-Lys-Tyr-SerPro-NH2 was synthesized toward encompassing the "active site" of the interferons. The design of this 29-amino acid peptide was based on considerations of homology between the different interferons and on combining two regions of interferons, and on known and predicted structural features. The peptide was characterized by amino acid analysis, thin layer chromatography in several systems, and by HPLC. As tested, the peptide neither showed antiviral activity nor blocked antiviral activity of interferon, indicating that the active site was not encompassed or that interferon may not be a sychnologieal peptide.
Introduction
Interferons were originally discovered as proteins produced by certain eucaryotic cells in response to a virus challenge [1] . Many biological effects have since "then been attributed to interferons, such as inhibition of growth and modulatory influence on the immune system [2, 3] . The a and ß types are induced by certain viruses, bacteria and doublestranded RNA. The y interferon is induced in lymphoid cells by mitogens and antigens to which the cells had been sensitized. The interferon is then excreted from the cells and bind to surface receptors of responsive cells and trigger the various biological responses [4, 5] . Pestka provided a comprehensive and excellent review of the human interferons in 1982 [6] ,
Experimental

General
The ROC-amino acids were purchased from Peninsula Laboratories, San Carlos, CA. Side chain protection was provided by benzyl esters for Asp and Glu, and ethers for Ser and Thr. The side chains of His and Arg were protected as tosyl derivatives, and the phenolic hydroxyl of Tyr and the £-amino group of Lys were protected as the Br-Z and Cl-Z derivatives, respectively. The benzhydrylamine (BHA) resin was obtained as its hydrochloride from Beckman Instruments, Inc., Palo Alto, CA. The amino acid analyses were carried out on a 118 CL amino acid analyzer from Beckman after hydrolysis The spots were visualized with the chlorine-otolidine reagent. In all chromatography, the fractions were checked by TLC in solvent system A.
Synthesis
The synthesis was carried out on a Beckman Model 990 peptide synthesizer. In the first step, 1 g of BHA resin with a substitution of 0.66 mmol/g was acylated with 0.4 nmol Pro as the symmetrical anhydride [7] . Then the resin was acetylated. For the synthesis, a standard protocol [8] was followed except that the amino acids to be coupled were added as their corresponding symmetrical anhydrides in four to five-fold excess. Diisopropylethyl amine was used instead of triethylamine in the neutralization step. The completeness of the couplings was checked by the Kaiser ninhydrin test [9] . If a second coupling was necessary, it was performed as a reversed DCC coupling [10] . BOC-glutamine was coupled as its p-nitrophenyl ester in the presence of one equivalent of HOBt in 50% DMF in CH2C12 [10] .
Purification and characterization of the peptide
After the completion of the couplings, the peptideresin weighed 2.6 g. 1.28 g of this product was treated with doubly distilled hydrogen fluoride containing 10-15% of anisole for 1 h at 0 °C, as described [11] . After work-up [11] , the yield of the crude peptide was 425 mg.
The crude peptide was first purified in two runs on a G-50 (fine) column. 2.5 X 110 cm, with 5% acetic acid as the eluant. The yield of the main product was 210 mg. The unwanted anions that might be present were then replaced by acetate on an AG1-X8 column (Bio-Rad). This product was then chromatographed by partition on a G-25 column, 2.5 X 110 cm, equilibrated with the lower and upper phases of the solvent system 1-butanolacetic acid-water, 4:1:5, flow rate, 0.6 ml/min; 7.2 ml fractions were collected. Fractions 115-159 were pooled and lyophilized; yield, 39 mg. Further purification was achieved by partition chromatography on G-25 with the solvent system 1-butanolpvridine -0.1% acetic acid 5:3:11; 2.5 X 110 cm column; 0.6 ml/min flow rate. The product appeared in fractions 30-39, yield, 30 mg.
Final purification was by ion exchange chromatography on CM-cellulose (Whatman). The sample was dissolved in 3 ml of 0.02 M NH4OAc, pH 6.5, and the solution was applied on a 1.5x15 cm column equilibrated with the same solvent. First, the column was eluted with 30 ml of this solvent, and then with a gradient made from mixing 600 ml of 0.8 M NH4OAC with 600 ml of starting buffer. The flow rate was ~0.4 ml/min; 5 ml fractions were collected. The peptide appeared in fractions 27-45. In addition to TLC, the fractions were also checked by UV absorbance at 259 nm; yield, 12 mg. Dr. Sidney Pestka, Roche Institute of Molecular Biology, Nutley, NJ, bioassayed the peptide, but observed no antiviral activity, and the peptide did not block the antiviral activity of interferon.
Results and Discussion
There have been studies by us [12] and others [13, 14] to synthesize fragments of interferon a to determine whether the antiviral activity is located within a certain part of the molecule. To date, antiviral activity has not been found for any of the fragments. This could mean that interferon is not a sychnological peptide; Schwyzer [15] used the word ' 'sychnological'' to differentiate relatively low molecular weight peptides which have active sites from larger polypeptides of proteins which have secondary tertiary structures that are essential for biological activity. In other words, the activity may not only be determined by the amino acid sequence, but by the three-dimensional structure. The folding of the chains may be contributory. Perhaps, the w T hole molecule is needed for activity, or an appropriate fragment which may have activity has not yet been achieved.
Alternatively, the three-dimensional structure may have two (or more) regions in the molecule which are in the proper position for interaction with the receptor. It has recently been proposed [16] , through investigations using hybrid interferons a [16, 17] , that the molecule possesses either two binding sites or two regions, idiotopes, which constitute the binding site. One of these regions was proposed to be located in the amino proximal part of the molecule and the other region was proposed to be in the carboxy proximal part.
Based on this concept of idiotopes, we selected and connected them to form a sequence that might resemble a possible active site. To do this, homology between different interferons, known and predicted structural features were considered. Among the human a interferons, the region with the highest degree of homology has the amino acids (115-150) [18] . Also, the region of the amino acids 28-50 have considerable homology. It is interesting that homology in these regions largely extends to human ß [19] and mouse a [20] interferons. Consequently, it seemed reasonable that these two regions might be important for receptor binding.
It has been proposed that the disulfide bond between Cys residues 31 and 141 in IFN/?, is essential since the substitution Cys 141 ->Tyr 141 abolishes antiviral activity [21] . Reductive cleavage of the corresponding bond in the a series, Cys 29 -Cys 138 [22] , also abolishes the antiviral activity, but activity is restored upon reformation of the bond [23] . The homology between IFNa, IFN/? and MuIFNa is also especially conspicuous in the regions around this bridge (Fig. 1) . The role of this bridge might be to form a functional site by holding the important amino acid residues together.
In the prediction of the secondary and tertiary structure of interferon by Sternberg and Cohen [24] . two ^-strands were suggested, namely the residues 32-36 and 125-133. These ^-strands are included in the above mentioned region close to the disulfide bridge where a high degree of homology is maintained (Fig. 1) . McCray and Weil [25] , using affinity labeling, proposed that a histidine residue in mouse and rabbit interferon is essential for activity. Whether this is true also for human a and ß interferons seems not to be known, but there are several His residues in the sequences in Fig. 1 . This background information indicated that the two /S-strands could form an adequately well-defined structural element to interact with the receptor and elicit the response. The straightforward approach to synthesizing a peptide featuring these /^-strands would be to make the peptides AcIFNaA (43-29) and AcIFNaA (123-138) and join them by disulfide formation. The oxidation step would, however, yield four different products with concomitant separation problems. Alternatively, the peptide AcIFNaA (30-43)-(123-137)-NH2 (Fig. 2) was synthesized by the solid-phase method. First Pro 137 was attached to the benzhydrylamine resin and then stepwise couplings were performed until Phe 123 has been attached. The synthesis was then continued with the residues Phe 43 -Leu 30 . This protected peptide was then cleaved from the resin, and purified by gel filtration, partition chromatography and ion exchange chromatography. The peptide was characterized by amino acid analysis, thin layer chromatography and HPLC.
If this peptide contains a /?-turn, it is conceivable that a ^-structure w ould form which would resemble the predicted [24] /^-structure for the interferon molecule. Considering the sequence from residues 39 through 42, Pro-Gln-Glu-Glu, a ß-tnrn should be favored [26] ,
The synthetic AcIFNaA (30^3)-(123-137)-NH2 was tested for antiviral activity but none was found. Also, this peptide did not block the antiviral activity of interferon [27] . Possibly, the entire molecule (except for thirteen amino acids at the C-terminal) is necessary for activity [23] . Possibly, the structural elements of this synthetic peptide are involved in binding, but the moedel is too simplified. Wetzel et al. [23] discussed active sites of interferon. It seems that these regions with the high degree of homology would be involved in binding, but perhaps this is not true. If the effective site for antiviral activity could be discerned and synthesized, the result could be an important breakthrough in interferon research.
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